Recruiting NA Juvenile; Scoliosis

New treatment option for Juvenile; Scoliosis

Official title Studying Melatonin and Recovery in Teens

ClinicalTrials.gov ID: NCT06093477

What this study is testing

What it's testing
The goal of this feasibility clinical trial is to learn if melatonin can help teens having major musculoskeletal surgery by promoting healthy sleep. Melatonin is available as a dietary supplement that may be effective in promoting longer, higher quality sleep.
  • Time commitment: about 4 months
  • You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 12 to 18

You may be able to join if

  • Patients/youth:
  • Age 12-18 years
  • Participants undergoing elective major musculoskeletal surgery for eligible conditions
  • California state resident
  • Regular access to internet and smartphone

You likely can't join if

  • Patients/youth
  • Prescription medication for premorbid insomnia
  • Cognitive impairment or developmental delay
  • Does not agree to a 1-week washout if taking over the counter supplements or other sleep aids prior to the start of the study medication
  • High risk for sleep related breathing disorder
  • Chronic medical condition that is severe/systemic or requires regular treatment regimen
See the full eligibility criteria
Who can join
  • Patients/youth:
  • Age 12-18 years
  • Participants undergoing elective major musculoskeletal surgery for eligible conditions
  • California state resident
  • Regular access to internet and smartphone
  • Can read and understand English or Spanish Parents/caregivers
  • Biological parent or legal guardian of youth
  • Can read and understand English or Spanish
What rules you out
  • Patients/youth
  • Prescription medication for premorbid insomnia
  • Cognitive impairment or developmental delay
  • Does not agree to a 1-week washout if taking over the counter supplements or other sleep aids prior to the start of the study medication
  • High risk for sleep related breathing disorder
  • Chronic medical condition that is severe/systemic or requires regular treatment regimen
  • Psychiatric admission in prior 30 days
  • Patients that underwent major surgery in the last 3 months, or those that have not fully recovered from a prior surgery
  • BMI ≥ 99th percentile
  • Enrollment in another therapeutic study
  • Any serious underlying medical or psychiatric condition, that, in the opinion of the investigator, would contraindicate the patient's participation in the study

The study team makes the final eligibility decision.

Where it's taking place

  • Palo Alto, California, United States

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The study runs about 4 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.

Who can join this trial?

This study is enrolling all sexes, 12 years to 18 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Palo Alto, California, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.